Attention
This section of the web-site contains information on medicines, advertising of which is not foreseen by the legislation. Information in this section is intended for reference only, has exclusively scientific and informative character and should not be treated as advertising information for a wide range of people. According to the current legislation, access to this information is granted to medical and pharmaceutical employees. Please confirm that you are a medical or pharmaceutical employee.

Endofalk®

Endofalk is recommended as a means of preparing the intestine for colonoscopy, X-ray and other studies of the intestine and surgical interventions that require the absence of intestinal contents (chyme).

The second generation of drugs, to which Endofalk belongs, does not contain sodium sulfate, but due to the similar water-electrolyte balance, it has identical osmolarity (288 vs. 280 mosm / kg) and is well tolerated by patients.

Fundamental research conducted by Fordtran * showed that the electrolytes contained in Endofalk have little or no effect on the metabolism of the body's own electrolytes.

To the high content of PEG (macrogol) and high osmolarity (288 mosm / kg), when using the drug, there is no movement of water between the intestinal lumen and the vascular bed.

Endofalc does not contain sodium sulfate, has a pleasant balanced taste of orange and passion fruit and is well tolerated by patients.

Before use, read the instructions and consult your doctor. There are contraindications and possible side effects. Not recommended for use during pregnancy and lactation and children under 12 years.

* Fordtran, J.S. et al. A low-sodium solution for gastrointestinal lavage. Gastroenterology 98: 11–16 (1990)

0

Ask a question

To prevent automated spam submissions leave this field empty.